Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …

Idiopathic pulmonary fibrosis (IPF) is a fibroproliferative disorder limited to the lung. New
findings, starting from our proteomics studies on IPF, suggest that systemic involvement with …

Background Pirfenidone and nintedanib are the sole pharmacological therapies currently
approved for idiopathic pulmonary fibrosis (IPF). Limited comparison data is available in …

Simple Summary Evaluation of the prognostic significance of serial measurements of serum
concentrations of Krebs von den Lungen-6 (KL-6) showed that an annual increment in KL-6 …

Idiopathic pulmonary fibrosis (IPF) is a chronic lung fibrosing disease with high prevalence
that has a prognosis worse than many cancers. There has been a recent influx of new …

Bronchiolitis obliterans syndrome (BOS) is the most common form of CLAD and is
characterized by airflow limitation and an obstructive spirometric pattern without high …

Background: Extracellular vesicles (EVs) are secreted by cells from their membrane within
circulation and body fluids. Knowledge of the involvement of EVs in pathogenesis of lung …

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic pulmonary
disease with rising incidence. In this study the effectiveness of pirfenidone, as measured by …

Background Broncho-alveolar lavage (BAL) is a safe diagnostic procedure, useful for
differentiating fibrotic lung disorders and for excluding malignancy and infection. A recent …

Idiopathic pulmonary fibrosis (IPF) and sarcoidosis are two distinct clinical entities with
different aetiology, epidemiology, risk factors, symptoms and chest imaging. A number of …